Share Price and Basic Stock Data
Last Updated: March 16, 2026, 3:48 am
| PEG Ratio | 0.00 |
|---|
📊 Last updated
18d ago
Feb 26, 2026
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Mcleod Russel India Ltd operates in the plantations industry, specifically focusing on tea and coffee. The company’s stock price stood at ₹41.5, with a market capitalization of ₹434 Cr. Over the past several quarters, Mcleod Russel has experienced fluctuating sales, with the most recent quarterly sales reported at ₹366 Cr in September 2023, recovering from a low of ₹226 Cr in March and June 2023. However, the revenue trend shows volatility, with total sales for the year ended March 2025 recorded at ₹1,185 Cr, slightly rising from ₹1,136 Cr in March 2024 but down from ₹1,370 Cr in March 2023. The company’s operational capacity appears underutilized, as indicated by the decline in sales compared to previous fiscal years, reflecting challenges in maintaining consistent revenue growth amid competitive pressures in the tea and coffee sectors.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Mcleod Russel India Ltd | 386 Cr. | 37.1 | 68.7/29.4 | 6.08 | 0.00 % | 1.85 % | 142 % | 5.00 | |
| Goodricke Group Ltd | 320 Cr. | 148 | 240/145 | 110 | 149 | 0.00 % | 3.22 % | 2.86 % | 10.0 |
| United Nilgiri Tea Estates Company Ltd (UNITEDTEA) | 252 Cr. | 504 | 589/360 | 11.4 | 465 | 0.59 % | 10.1 % | 8.70 % | 10.0 |
| Peria Karamalai Tea & Produce Company Ltd (PKTEA) | 247 Cr. | 797 | 1,014/565 | 294 | 618 | 0.13 % | 1.50 % | 0.45 % | 10.0 |
| Rossell India Ltd | 176 Cr. | 46.2 | 87.1/40.0 | 9.90 | 59.2 | 0.86 % | 10.5 % | 10.8 % | 2.00 |
| Industry Average | 8,312.29 Cr | 373.00 | 51.85 | 265.00 | 0.46% | 7.88% | 16.74% | 7.00 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 489 | 226 | 226 | 366 | 349 | 195 | 197 | 453 | 371 | 165 | 216 | 363 | 445 |
| Expenses | 517 | 326 | 231 | 243 | 389 | 381 | 185 | 295 | 397 | 291 | 209 | 264 | 438 |
| Operating Profit | -28 | -100 | -5 | 123 | -40 | -186 | 12 | 158 | -26 | -125 | 7 | 98 | 8 |
| OPM % | -6% | -44% | -2% | 34% | -12% | -96% | 6% | 35% | -7% | -76% | 3% | 27% | 2% |
| Other Income | 3 | -928 | 3 | 2 | 5 | 6 | 21 | 1 | 1 | 1 | 2 | 1 | 0 |
| Interest | 40 | 74 | 55 | 48 | 47 | 54 | 48 | 49 | 62 | 67 | 46 | 47 | 44 |
| Depreciation | 18 | 17 | 16 | 18 | 16 | 16 | 15 | 15 | 15 | 16 | 15 | 15 | 15 |
| Profit before tax | -84 | -1,120 | -73 | 60 | -98 | -250 | -30 | 95 | -102 | -207 | -52 | 37 | -51 |
| Tax % | -16% | -4% | -1% | -3% | -17% | -13% | -31% | 11% | -15% | -16% | -16% | 22% | -28% |
| Net Profit | -71 | -1,078 | -73 | 61 | -82 | -218 | -21 | 85 | -87 | -174 | -43 | 29 | -36 |
| EPS in Rs | -6.78 | -103.23 | -6.96 | 5.85 | -7.82 | -20.91 | -1.98 | 8.09 | -8.36 | -16.70 | -4.16 | 2.78 | -3.49 |
Last Updated: March 3, 2026, 9:46 pm
Below is a detailed analysis of the quarterly data for Mcleod Russel India Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 445.00 Cr.. The value appears strong and on an upward trend. It has increased from 363.00 Cr. (Sep 2025) to 445.00 Cr., marking an increase of 82.00 Cr..
- For Expenses, as of Dec 2025, the value is 438.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 264.00 Cr. (Sep 2025) to 438.00 Cr., marking an increase of 174.00 Cr..
- For Operating Profit, as of Dec 2025, the value is 8.00 Cr.. The value appears to be declining and may need further review. It has decreased from 98.00 Cr. (Sep 2025) to 8.00 Cr., marking a decrease of 90.00 Cr..
- For OPM %, as of Dec 2025, the value is 2.00%. The value appears to be declining and may need further review. It has decreased from 27.00% (Sep 2025) to 2.00%, marking a decrease of 25.00%.
- For Other Income, as of Dec 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Sep 2025) to 0.00 Cr., marking a decrease of 1.00 Cr..
- For Interest, as of Dec 2025, the value is 44.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 47.00 Cr. (Sep 2025) to 44.00 Cr., marking a decrease of 3.00 Cr..
- For Depreciation, as of Dec 2025, the value is 15.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 15.00 Cr..
- For Profit before tax, as of Dec 2025, the value is -51.00 Cr.. The value appears to be declining and may need further review. It has decreased from 37.00 Cr. (Sep 2025) to -51.00 Cr., marking a decrease of 88.00 Cr..
- For Tax %, as of Dec 2025, the value is -28.00%. The value appears to be improving (decreasing) as expected. It has decreased from 22.00% (Sep 2025) to -28.00%, marking a decrease of 50.00%.
- For Net Profit, as of Dec 2025, the value is -36.00 Cr.. The value appears to be declining and may need further review. It has decreased from 29.00 Cr. (Sep 2025) to -36.00 Cr., marking a decrease of 65.00 Cr..
- For EPS in Rs, as of Dec 2025, the value is -3.49. The value appears to be declining and may need further review. It has decreased from 2.78 (Sep 2025) to -3.49, marking a decrease of 6.27.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: February 25, 2026, 1:16 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,789 | 1,646 | 1,926 | 1,871 | 2,055 | 1,723 | 1,143 | 1,438 | 1,356 | 1,370 | 1,136 | 1,185 | 1,190 |
| Expenses | 1,436 | 1,516 | 1,754 | 1,761 | 1,903 | 1,763 | 1,101 | 1,243 | 1,288 | 1,275 | 1,245 | 1,164 | 1,201 |
| Operating Profit | 353 | 130 | 172 | 110 | 152 | -41 | 42 | 195 | 68 | 95 | -109 | 21 | -12 |
| OPM % | 20% | 8% | 9% | 6% | 7% | -2% | 4% | 14% | 5% | 7% | -10% | 2% | -1% |
| Other Income | 42 | 43 | 88 | 184 | 382 | 523 | 73 | 20 | 10 | -918 | 17 | 22 | 4 |
| Interest | 60 | 72 | 109 | 136 | 180 | 338 | 227 | 205 | 165 | 201 | 203 | 226 | 204 |
| Depreciation | 38 | 77 | 102 | 104 | 102 | 84 | 78 | 90 | 75 | 70 | 66 | 61 | 61 |
| Profit before tax | 297 | 25 | 49 | 55 | 252 | 61 | -189 | -80 | -162 | -1,093 | -362 | -245 | -272 |
| Tax % | 12% | -38% | 29% | -18% | 13% | 36% | -22% | -34% | 12% | -3% | -14% | -19% | |
| Net Profit | 261 | 33 | 35 | 64 | 219 | 39 | -148 | -52 | -181 | -1,057 | -312 | -198 | -225 |
| EPS in Rs | 23.49 | 2.85 | 2.56 | 5.35 | 19.00 | 3.05 | -14.15 | -5.02 | -17.32 | -101.14 | -29.83 | -18.94 | -21.57 |
| Dividend Payout % | 30% | 105% | 59% | 4% | 2% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -87.36% | 6.06% | 82.86% | 242.19% | -82.19% | -479.49% | 64.86% | -248.08% | -483.98% | 70.48% | 36.54% |
| Change in YoY Net Profit Growth (%) | 0.00% | 93.42% | 76.80% | 159.33% | -324.38% | -397.30% | 544.35% | -312.94% | -235.90% | 554.46% | -33.94% |
Mcleod Russel India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -3% |
| 5 Years: | 1% |
| 3 Years: | -4% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -3% |
| 3 Years: | -7% |
| TTM: | 22% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -13% |
| 5 Years: | 15% |
| 3 Years: | 16% |
| 1 Year: | 46% |
| Return on Equity | |
|---|---|
| 10 Years: | -7% |
| 5 Years: | -17% |
| 3 Years: | -39% |
| Last Year: | -142% |
Last Updated: Unknown
Balance Sheet
Last Updated: December 4, 2025, 1:38 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 55 | 55 | 41 | 41 | 46 | 44 | 52 | 52 | 52 | 52 | 52 | 52 | 52 |
| Reserves | 2,102 | 2,037 | 1,909 | 1,918 | 2,121 | 1,971 | 1,802 | 1,771 | 1,596 | 517 | 198 | 4 | 11 |
| Borrowings | 304 | 602 | 836 | 936 | 1,091 | 1,812 | 2,346 | 2,261 | 2,089 | 1,961 | 1,893 | 1,902 | 1,911 |
| Other Liabilities | 427 | 395 | 604 | 557 | 585 | 733 | 735 | 824 | 1,025 | 1,209 | 1,393 | 1,636 | 1,782 |
| Total Liabilities | 2,888 | 3,089 | 3,390 | 3,452 | 3,843 | 4,559 | 4,935 | 4,908 | 4,763 | 3,740 | 3,536 | 3,594 | 3,756 |
| Fixed Assets | 2,073 | 2,165 | 2,164 | 2,137 | 2,120 | 1,475 | 1,426 | 1,397 | 1,395 | 1,386 | 1,280 | 1,260 | 1,244 |
| CWIP | 53 | 63 | 96 | 91 | 107 | 89 | 93 | 67 | 56 | 47 | 45 | 41 | 47 |
| Investments | 13 | 12 | 78 | 72 | 96 | 101 | 11 | 53 | 62 | 52 | 62 | 58 | 70 |
| Other Assets | 749 | 848 | 1,051 | 1,151 | 1,520 | 2,893 | 3,406 | 3,391 | 3,250 | 2,254 | 2,148 | 2,234 | 2,395 |
| Total Assets | 2,888 | 3,089 | 3,390 | 3,452 | 3,843 | 4,559 | 4,935 | 4,908 | 4,763 | 3,740 | 3,536 | 3,594 | 3,756 |
Below is a detailed analysis of the balance sheet data for Mcleod Russel India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 52.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 52.00 Cr..
- For Reserves, as of Sep 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Mar 2025) to 11.00 Cr., marking an increase of 7.00 Cr..
- For Borrowings, as of Sep 2025, the value is 1,911.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 1,902.00 Cr. (Mar 2025) to 1,911.00 Cr., marking an increase of 9.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1,782.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,636.00 Cr. (Mar 2025) to 1,782.00 Cr., marking an increase of 146.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 3,756.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,594.00 Cr. (Mar 2025) to 3,756.00 Cr., marking an increase of 162.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,244.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,260.00 Cr. (Mar 2025) to 1,244.00 Cr., marking a decrease of 16.00 Cr..
- For CWIP, as of Sep 2025, the value is 47.00 Cr.. The value appears strong and on an upward trend. It has increased from 41.00 Cr. (Mar 2025) to 47.00 Cr., marking an increase of 6.00 Cr..
- For Investments, as of Sep 2025, the value is 70.00 Cr.. The value appears strong and on an upward trend. It has increased from 58.00 Cr. (Mar 2025) to 70.00 Cr., marking an increase of 12.00 Cr..
- For Other Assets, as of Sep 2025, the value is 2,395.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,234.00 Cr. (Mar 2025) to 2,395.00 Cr., marking an increase of 161.00 Cr..
- For Total Assets, as of Sep 2025, the value is 3,756.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,594.00 Cr. (Mar 2025) to 3,756.00 Cr., marking an increase of 162.00 Cr..
However, the Borrowings (1,911.00 Cr.) are higher than the Reserves (11.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 49.00 | -472.00 | -664.00 | -826.00 | 151.00 | -42.00 | 40.00 | 193.00 | 66.00 | 94.00 | -110.00 | 20.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 10 | 19 | 24 | 21 | 22 | 8 | 11 | 8 | 13 | 11 | 15 | 15 |
| Inventory Days | 281 | 354 | 244 | 274 | 251 | 275 | 1,208 | 352 | 288 | 422 | 343 | |
| Days Payable | 101 | 169 | 132 | 135 | 136 | 212 | 555 | 192 | 204 | 349 | 345 | |
| Cash Conversion Cycle | 189 | 204 | 135 | 161 | 137 | 71 | 664 | 168 | 97 | 84 | 13 | 15 |
| Working Capital Days | -14 | 0 | 14 | 7 | 58 | -345 | -734 | -624 | -661 | -708 | -933 | -944 |
| ROCE % | 15% | 4% | 6% | 6% | 8% | 3% | -0% | 3% | 0% | 1% | -7% | -2% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Basic EPS (Rs.) | -18.94 | -29.83 | -101.14 | -17.32 | -5.02 |
| Diluted EPS (Rs.) | -18.94 | -29.83 | -101.14 | -17.32 | -5.02 |
| Cash EPS (Rs.) | -13.08 | -23.53 | -94.45 | -10.16 | 3.64 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | -17.55 | -0.09 | 29.39 | 131.63 | 147.22 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 5.42 | 23.94 | 54.50 | 157.84 | 174.55 |
| Revenue From Operations / Share (Rs.) | 113.48 | 108.74 | 131.12 | 129.80 | 137.71 |
| PBDIT / Share (Rs.) | 2.25 | -9.33 | 10.57 | 7.48 | 20.60 |
| PBIT / Share (Rs.) | -3.61 | -15.63 | 3.88 | 0.31 | 11.95 |
| PBT / Share (Rs.) | -23.41 | -34.61 | -104.68 | -15.53 | -7.63 |
| Net Profit / Share (Rs.) | -18.94 | -29.83 | -101.14 | -17.32 | -5.02 |
| NP After MI And SOA / Share (Rs.) | -18.94 | -29.83 | -101.14 | -17.32 | -5.02 |
| PBDIT Margin (%) | 1.98 | -8.57 | 8.06 | 5.76 | 14.95 |
| PBIT Margin (%) | -3.18 | -14.36 | 2.95 | 0.24 | 8.67 |
| PBT Margin (%) | -20.63 | -31.83 | -79.83 | -11.96 | -5.54 |
| Net Profit Margin (%) | -16.69 | -27.43 | -77.14 | -13.34 | -3.64 |
| NP After MI And SOA Margin (%) | -16.69 | -27.43 | -77.14 | -13.34 | -3.64 |
| Return on Networth / Equity (%) | 0.00 | 0.00 | -344.11 | -13.15 | -3.40 |
| Return on Capital Employeed (%) | -13.62 | -38.99 | 5.20 | 0.17 | 5.98 |
| Return On Assets (%) | -5.50 | -8.81 | -28.25 | -3.79 | -1.06 |
| Long Term Debt / Equity (X) | -0.53 | -52.00 | 0.23 | 0.08 | 0.07 |
| Total Debt / Equity (X) | -10.38 | -1970.69 | 6.38 | 1.52 | 1.31 |
| Asset Turnover Ratio (%) | 0.33 | 0.31 | 0.32 | 0.24 | 0.23 |
| Current Ratio (X) | 0.08 | 0.07 | 0.10 | 0.14 | 0.16 |
| Quick Ratio (X) | 0.05 | 0.03 | 0.05 | 0.07 | 0.08 |
| Inventory Turnover Ratio (X) | 11.37 | 9.05 | 0.44 | 0.81 | 0.73 |
| Interest Coverage Ratio (X) | 0.10 | -0.47 | 0.55 | 0.47 | 1.05 |
| Interest Coverage Ratio (Post Tax) (X) | 0.03 | -0.55 | 0.38 | -0.09 | 0.74 |
| Enterprise Value (Cr.) | 2245.84 | 2136.78 | 2120.15 | 2295.30 | 2115.56 |
| EV / Net Operating Revenue (X) | 1.89 | 1.88 | 1.55 | 1.69 | 1.47 |
| EV / EBITDA (X) | 95.50 | -21.93 | 19.20 | 29.38 | 9.83 |
| MarketCap / Net Operating Revenue (X) | 0.29 | 0.22 | 0.12 | 0.17 | 0.13 |
| Price / BV (X) | -1.93 | -262.62 | 0.57 | 0.17 | 0.12 |
| Price / Net Operating Revenue (X) | 0.29 | 0.22 | 0.12 | 0.17 | 0.13 |
| EarningsYield | -0.56 | -1.24 | -5.96 | -0.75 | -0.26 |
After reviewing the key financial ratios for Mcleod Russel India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -18.94. This value is below the healthy minimum of 5. It has increased from -29.83 (Mar 24) to -18.94, marking an increase of 10.89.
- For Diluted EPS (Rs.), as of Mar 25, the value is -18.94. This value is below the healthy minimum of 5. It has increased from -29.83 (Mar 24) to -18.94, marking an increase of 10.89.
- For Cash EPS (Rs.), as of Mar 25, the value is -13.08. This value is below the healthy minimum of 3. It has increased from -23.53 (Mar 24) to -13.08, marking an increase of 10.45.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -17.55. It has decreased from -0.09 (Mar 24) to -17.55, marking a decrease of 17.46.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 5.42. It has decreased from 23.94 (Mar 24) to 5.42, marking a decrease of 18.52.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 113.48. It has increased from 108.74 (Mar 24) to 113.48, marking an increase of 4.74.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 2.25. This value is within the healthy range. It has increased from -9.33 (Mar 24) to 2.25, marking an increase of 11.58.
- For PBIT / Share (Rs.), as of Mar 25, the value is -3.61. This value is below the healthy minimum of 0. It has increased from -15.63 (Mar 24) to -3.61, marking an increase of 12.02.
- For PBT / Share (Rs.), as of Mar 25, the value is -23.41. This value is below the healthy minimum of 0. It has increased from -34.61 (Mar 24) to -23.41, marking an increase of 11.20.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -18.94. This value is below the healthy minimum of 2. It has increased from -29.83 (Mar 24) to -18.94, marking an increase of 10.89.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -18.94. This value is below the healthy minimum of 2. It has increased from -29.83 (Mar 24) to -18.94, marking an increase of 10.89.
- For PBDIT Margin (%), as of Mar 25, the value is 1.98. This value is below the healthy minimum of 10. It has increased from -8.57 (Mar 24) to 1.98, marking an increase of 10.55.
- For PBIT Margin (%), as of Mar 25, the value is -3.18. This value is below the healthy minimum of 10. It has increased from -14.36 (Mar 24) to -3.18, marking an increase of 11.18.
- For PBT Margin (%), as of Mar 25, the value is -20.63. This value is below the healthy minimum of 10. It has increased from -31.83 (Mar 24) to -20.63, marking an increase of 11.20.
- For Net Profit Margin (%), as of Mar 25, the value is -16.69. This value is below the healthy minimum of 5. It has increased from -27.43 (Mar 24) to -16.69, marking an increase of 10.74.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -16.69. This value is below the healthy minimum of 8. It has increased from -27.43 (Mar 24) to -16.69, marking an increase of 10.74.
- For Return on Networth / Equity (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 15. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Return on Capital Employeed (%), as of Mar 25, the value is -13.62. This value is below the healthy minimum of 10. It has increased from -38.99 (Mar 24) to -13.62, marking an increase of 25.37.
- For Return On Assets (%), as of Mar 25, the value is -5.50. This value is below the healthy minimum of 5. It has increased from -8.81 (Mar 24) to -5.50, marking an increase of 3.31.
- For Long Term Debt / Equity (X), as of Mar 25, the value is -0.53. This value is below the healthy minimum of 0.2. It has increased from -52.00 (Mar 24) to -0.53, marking an increase of 51.47.
- For Total Debt / Equity (X), as of Mar 25, the value is -10.38. This value is within the healthy range. It has increased from -1,970.69 (Mar 24) to -10.38, marking an increase of 1,960.31.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.33. It has increased from 0.31 (Mar 24) to 0.33, marking an increase of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 0.08. This value is below the healthy minimum of 1.5. It has increased from 0.07 (Mar 24) to 0.08, marking an increase of 0.01.
- For Quick Ratio (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 1. It has increased from 0.03 (Mar 24) to 0.05, marking an increase of 0.02.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 11.37. This value exceeds the healthy maximum of 8. It has increased from 9.05 (Mar 24) to 11.37, marking an increase of 2.32.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 0.10. This value is below the healthy minimum of 3. It has increased from -0.47 (Mar 24) to 0.10, marking an increase of 0.57.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.03. This value is below the healthy minimum of 3. It has increased from -0.55 (Mar 24) to 0.03, marking an increase of 0.58.
- For Enterprise Value (Cr.), as of Mar 25, the value is 2,245.84. It has increased from 2,136.78 (Mar 24) to 2,245.84, marking an increase of 109.06.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.89. This value is within the healthy range. It has increased from 1.88 (Mar 24) to 1.89, marking an increase of 0.01.
- For EV / EBITDA (X), as of Mar 25, the value is 95.50. This value exceeds the healthy maximum of 15. It has increased from -21.93 (Mar 24) to 95.50, marking an increase of 117.43.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.29. This value is below the healthy minimum of 1. It has increased from 0.22 (Mar 24) to 0.29, marking an increase of 0.07.
- For Price / BV (X), as of Mar 25, the value is -1.93. This value is below the healthy minimum of 1. It has increased from -262.62 (Mar 24) to -1.93, marking an increase of 260.69.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.29. This value is below the healthy minimum of 1. It has increased from 0.22 (Mar 24) to 0.29, marking an increase of 0.07.
- For EarningsYield, as of Mar 25, the value is -0.56. This value is below the healthy minimum of 5. It has increased from -1.24 (Mar 24) to -0.56, marking an increase of 0.68.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Mcleod Russel India Ltd:
- Net Profit Margin: -16.69%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -13.62% (Industry Average ROCE: 7.88%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0% (Industry Average ROE: 16.74%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0.03
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.05
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 51.85)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: -10.38
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -16.69%
About the Company - Qualitative Analysis
McLeod Russel (India) Ltd. is a Public Limited Listed company incorporated on 05/05/1998 and has its registered office in the State of West Bengal, India. Company's Corporate Identification Number(CIN) is L51109WB1998PLC087076 and registration number is 087076. Currently Company is involved in the business activities of Growing of tea. Company's Total Operating Revenue is Rs. 1024.36 Cr. and Equity Capital is Rs. 52.23 Cr. for the Year ended 31/03/2025.
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Plantations - Tea & Coffee | Four Mangoe Lane, Kolkata West Bengal 700001 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Aditya Khaitan | Chairman & Managing Director |
| Mr. Amritanshu Khaitan | Non Executive Director |
| Mrs. Rupanjana De | Independent Director |
| Mr. Indrajit Sengupta | Independent Director |
| Mr. Amar Nath Dhar | Independent Director |
| Mr. Sanjay Ginodia | Independent Director |
FAQ
What is the intrinsic value of Mcleod Russel India Ltd?
Mcleod Russel India Ltd's intrinsic value (as of 16 March 2026) is ₹75.85 which is 104.45% higher the current market price of ₹37.10, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹386 Cr. market cap, FY2025-2026 high/low of ₹68.7/29.4, reserves of ₹11 Cr, and liabilities of ₹3,756 Cr.
What is the Market Cap of Mcleod Russel India Ltd?
The Market Cap of Mcleod Russel India Ltd is 386 Cr..
What is the current Stock Price of Mcleod Russel India Ltd as on 16 March 2026?
The current stock price of Mcleod Russel India Ltd as on 16 March 2026 is ₹37.1.
What is the High / Low of Mcleod Russel India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Mcleod Russel India Ltd stocks is ₹68.7/29.4.
What is the Stock P/E of Mcleod Russel India Ltd?
The Stock P/E of Mcleod Russel India Ltd is .
What is the Book Value of Mcleod Russel India Ltd?
The Book Value of Mcleod Russel India Ltd is 6.08.
What is the Dividend Yield of Mcleod Russel India Ltd?
The Dividend Yield of Mcleod Russel India Ltd is 0.00 %.
What is the ROCE of Mcleod Russel India Ltd?
The ROCE of Mcleod Russel India Ltd is 1.85 %.
What is the ROE of Mcleod Russel India Ltd?
The ROE of Mcleod Russel India Ltd is 142 %.
What is the Face Value of Mcleod Russel India Ltd?
The Face Value of Mcleod Russel India Ltd is 5.00.